Helix Nanotechnologies

Next-generation mRNA platform to solve cancer, COVID and climate. Status: Active. Batch: YC Winter 2017. HQ: Boston, MA, USA; Cambridge, MA, USA. Industry: Healthcare. http://helixnano.com

Details

city: Boston
cohort year: 2017
country: United States
exited: false
has patents: true
industry: healthcare
one liner: Next-generation mRNA platform to solve cancer, COVID and climate.
patent count estimate: 2
status: active
team size: 22
website: http://helixnano.com

person → founded2

Nikolai Eroshenko
Nikolai Eroshenko

based in → country1

United States

has research profile → company research profile1

helix_nanotechnologies research profile

accelerator → invested in1

Y Combinator

member of → category1

Healthtech

owns → patent1

Helix Nanotechnologies Patents

participated in → cohort1

Y Combinator Winter 2017